<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940817-2-00267</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=4 --> Risk assessment for neurotoxicity shares many common features with other noncancer  <!-- PJG 0012 frnewline --> toxicities such as developmental toxicity and immunotoxicity. As such, there are several  <!-- PJG 0012 frnewline --> generic assumptions that apply to all traditional, noncancer endpoint risk assessment  <!-- PJG 0012 frnewline --> procedures (Table 5&hyph;1).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 1,L1(,0,),p8,8/9,i1,s50 -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=95 g=1 f=4 --> Table  <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 --> 5&hyph;1._ <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=4 --> General Assumptions That Underlie Traditional Risk Assessments <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=5 f=1 --> a,b <!-- PJG /ITAG -->  <!-- PJG ITAG l=95 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1&blank; <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> 1. A threshold dose exists for noncancer endpoints.  <!-- PJG 0012 frnewline --> 2. NOAEL/LOAEL uncertainty- or safety-factor approaches are reasonable.  <!-- PJG 0012 frnewline --> 3. Variability in the toxic response to the chemical exposure is not due to a heterogeneous population response.  <!-- PJG 0012 frnewline --> 4. Average dose or total dose is a reasonable measure of exposure when doses are not  <!-- PJG 0012 frnewline --> equivalent in time, rate, or route of administration and the average (or total) dose is  <!-- PJG 0012 frnewline --> proportional to adverse effect.  <!-- PJG 0012 frnewline --> 5. Structure-activity correlations can be used to predict human toxicity.  <!-- PJG 0012 frnewline --> 6. The mechanism of action is the same at all doses for all species.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> aThis is not intended to be an exhaustive list.  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0146 intable -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=5 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=22 g=1 f=1 --> bModified from Sheehan et al., 1989.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            